We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$442M
AUM Growth
–
Cap. Flow
+$435M
Cap. Flow %
98.44%
Top 10 Hldgs %
49.11%
Holding
75
New
73
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$32.5M
2
ETN icon
Eaton
ETN
+$29.8M
3
PFE icon
Pfizer
PFE
+$27.7M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.3M
5
CMI icon
Cummins
CMI
+$20.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 31.69%
2 Communication Services 17.3%
3 Industrials 13.38%
4 Consumer Discretionary 8.56%
5 Real Estate 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
51
Bruker
BRKR
$7.66B
$641K 0.15%
+39,682
New +$686K
CI icon
52
Cigna
CI
$71.3B
$594K 0.13%
+8,192
New +$552K
TSRO
53
DELISTED
TESARO, Inc.
TSRO
$564K 0.13%
+17,230
New +$532K
ALGN icon
54
Align Technology
ALGN
$12.4B
$481K 0.11%
+12,975
New +$447K
REGN icon
55
Regeneron Pharmaceuticals
REGN
$79.3B
$421K 0.1%
+1,871
New +$436K
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
$416K 0.09%
+6,745
New +$406K
CFN
57
DELISTED
CAREFUSION CORPORATION
CFN
$403K 0.09%
+10,949
New +$387K
MOH icon
58
Molina Healthcare
MOH
$10.1B
$398K 0.09%
+10,715
New +$378K
EPZM
59
DELISTED
Epizyme, Inc
EPZM
$391K 0.09%
+13,887
New +$357K
COO icon
60
Cooper Companies
COO
$14.5B
$384K 0.09%
+12,900
New +$363K
EXAS
61
DELISTED
Exact Sciences
EXAS
$229K 0.05%
+16,473
New +$179K
GNMK
62
DELISTED
GenMark Diagnostics, Inc
GNMK
$214K 0.05%
+20,717
New +$286K
WAT icon
63
Waters Corp
WAT
$39B
$144K 0.03%
+1,435
New +$137K
IDIX
64
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$144K 0.03%
+39,991
New +$164K
GWPH
65
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$116K 0.03%
+13,156
New +$116K
RAD
66
DELISTED
Rite Aid Corporation
RAD
$99K 0.02%
+1,737
New +$90.6K
MRK icon
67
Merck
MRK
$316B
$72K 0.02%
+1,626
New +$72.6K
BB icon
68
BlackBerry
BB
$5.3B
$41K 0.01%
+3,893
New +$56.4K
MRK icon
69
CALL
Merck
MRK
$316B
$17K ﹤0.01%
+21,589
New +$964K
HCA icon
70
CALL
HCA Healthcare
HCA
$86.9B
$12K ﹤0.01%
+14,800
New +$573K
ISRG icon
71
PUT
Intuitive Surgical
ISRG
$132B
$4K ﹤0.01%
+2,700
New +$149K
VOLC
72
CALL
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$3K ﹤0.01%
+3,300
New +$63.1K
ZTS icon
73
Zoetis
ZTS
$31.6B
$0 ﹤0.01%
+5
New +$162
1 2
3

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Partner Investment Management, which disclosed 75 positions worth $442M. Its ten largest holdings account for 49% of the portfolio.

Its largest position is Gilead Sciences: 623,395 shares worth $32M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, followed by Communication Services and Industrials.

  • Partner Investment Management's largest Q2 2013 buy was Gilead Sciences: 623,395 shares worth $32M.
  • Partner Investment Management's ten largest holdings make up 49% of its $442M portfolio in Q2 2013.
  • Partner Investment Management disclosed 75 positions in Q2 2013, its first 13F filing on record.

Based on Partner Investment Management's 13F filing for Q2 2013, filed 14 Aug 2013.